Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 119

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 119
---
  34,650 |     | $                                      | — |     | $                                           | — |     | $                      | — |     | $     | 339,252 |
| Joseph Palumbo                                             |     |      |     |        |         |     |       |   |     |                  |        |     |                   |         |     |                                        |   |     |                                             |   |     |                        |   |     |       |         |
| Chief Medical Officer                                      |     | 2025 |     | $      | 560,000 |     | $     | — |     | $                |      — |     | $                 |  22,051 |     | $                                      | — |     | $                                           | — |     | $                      | — |     | $     | 582,051 |
|                                                            |     | 2024 |     | $      | 560,000 |     | $     | — |     | $                | 54,984 |     | $                 |  54,600 |     | $                                      | — |     | $                                           | — |     | $                      | — |     | $     | 669,584 |

| (1) | The aggregate grant date fair value of such awards were computed                                                                        
 in accordance with Financial Accounting Standards Board ASC Topic 718, Stock Compensation (ASC Topic 718), and do not take into account 
 estimated forfeitures related to service-based vesting conditions, if any. The valuation assumptions used in calculating these values   
 are discussed in Note 10 of our Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended June 30,    
 2024. These amounts do not represent actual amounts paid or to be realized. Amounts shown are not necessarily indicative of values to   
 be achieved, which may be more or less than the amounts shown as awards may subject to time-based vesting. The stock awards in form of  
 RSUs and Stock Option Awards were awarded pursuant to the 2019 Plan.                                                                    |

Narrative Disclosures to Summary Compensation Table

Employment Agreements

All employment arrangements are “at will” agreements.

<div align='center'>65</div>

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth all outstanding equity awards held by
our named executive officers as of June 30, 2025:

| Name                   |     | Grant Date |     | Options                                                         
 Number of